Table 2 Summary the DVH analysis for the reference and the RapidPlan plans for the entire cohort of validation patients from the 3 clinics
| Â | Objective | Reference | RapidPlan | p |
|---|---|---|---|---|
PTV | ||||
 Mean [%] | 100 % | 100.0 ± 0.0 | 100.0 ± 0.0 | - |
 D1% [%] | <107 % | 104.2 ± 3.2 | 103.8 ± 3.1 | - |
 V95% [%] | >95 % | 97.3 ± 2.9 | 98.0 ± 1.2 | - |
 St. Dev. [%] | <5 % | 2.1 ± 0.1 | 2.0 ± 0.1 | - |
Left lung | ||||
 Mean [Gy] | <15Gy | 8.9 ± 4.2 | 9.1 ± 4.8 | - |
 V20Gy [%] | <20% | 12.4 ± 10.2 | 12.6 ± 11.0 | - |
Right lung | ||||
 Mean [Gy] | <15Gy | 9.2 ± 4.8 | 9.1 ± 5.2 | - |
 V20Gy [%] | <20 % | 12.1 ± 11.3 | 12.2 ± 11.7 | - |
Heart | ||||
 Mean [Gy] | <25Gy | 11.9 ± 9.9 | 10.7 ± 8.3 | 0.03 |
 V30Gy [%] | <30 % | 10.3 ± 16.1 | 7.0 ± 8.9 | 0.07 |
Spine | ||||
 D1cm3 [Gy] | <45Gy | 26.2 ± 11.5 | 23.6 ± 9.7 | 0.001 |
Liver | ||||
 Mean | <15Gy | 8.5 ± 5.9 | 8.6 ± 6.4 | - |
Spleen | ||||
 Mean [Gy] | <20Gy | 14.3 ± 7.6 | 12.3 ± 6.3 | 0.004 |
 D1% [Gy] | <40Gy | 32.6 ± 10.6 | 30.6 ± 11.0 | - |
Left kidney | ||||
 V15Gy [%] | <35 % | 16.4 ± 16.9 | 12.7 ± 18.7 | 0.03 |
Right kidney | ||||
 V15Gy [%] | <35 % | 4.7 ± 7.3 | 3.4 ± 5.0 | - |
Stomach | ||||
 D1% [Gy] | <50Gy | 43.3 ± 8.8 | 42.5 ± 9.9 | 0.07 |
Small bowel | ||||
 Mean [Gy] | <10Gy | 6.6 ± 3.1 | 6.3 ± 3.0 | 0.03 |
 D1% [Gy] | <45Gy | 25.6 ± 9.2 | 24.6 ± 8.6 | - |